25 XP   0   0   10

Aroa Biosurgery Ltd
Buy, Hold or Sell?

Let's analyse Aroa Biosurgery Ltd together

PenkeI guess you are interested in Aroa Biosurgery Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aroa Biosurgery Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Aroa Biosurgery Ltd

I send you an email if I find something interesting about Aroa Biosurgery Ltd.

Quick analysis of Aroa Biosurgery Ltd (30 sec.)










What can you expect buying and holding a share of Aroa Biosurgery Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
A$0.28
Expected worth in 1 year
A$0.30
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$0.02
Return On Investment
4.0%

For what price can you sell your share?

Current Price per Share
A$0.57
Expected price per share
A$0.5375 - A$0.6
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Aroa Biosurgery Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.57

2. Growth of Aroa Biosurgery Ltd (5 min.)




Is Aroa Biosurgery Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$61.9m$60.7m$1.2m2.1%

How much money is Aroa Biosurgery Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$240.9k-$5m$4.8m2,002.7%
Net Profit Margin-0.6%-21.1%--

How much money comes from the company's main activities?

3. Financial Health of Aroa Biosurgery Ltd (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Aroa Biosurgery Ltd? (5 min.)

Welcome investor! Aroa Biosurgery Ltd's management wants to use your money to grow the business. In return you get a share of Aroa Biosurgery Ltd.

What can you expect buying and holding a share of Aroa Biosurgery Ltd?

First you should know what it really means to hold a share of Aroa Biosurgery Ltd. And how you can make/lose money.

Speculation

The Price per Share of Aroa Biosurgery Ltd is A$0.57. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aroa Biosurgery Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aroa Biosurgery Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.28. Based on the TTM, the Book Value Change Per Share is A$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aroa Biosurgery Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-0.1%0.00-0.1%-0.02-2.8%-0.01-2.2%-0.01-1.3%
Usd Book Value Change Per Share0.000.7%0.000.7%0.0813.2%0.046.2%0.022.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.011.2%0.000.6%
Usd Total Gains Per Share0.000.7%0.000.7%0.0813.2%0.047.4%0.023.5%
Usd Price Per Share0.68-0.68-0.50-0.42-0.54-
Price to Earnings Ratio-910.64--910.64--31.74--179.17--220.96-
Price-to-Total Gains Ratio182.59-182.59-6.70-60.37--66.59-
Price to Book Ratio3.78-3.78-2.85-3.95-34.62-
Price-to-Total Gains Ratio182.59-182.59-6.70-60.37--66.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.370443
Number of shares2699
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.000.04
Usd Total Gains Per Share0.000.04
Gains per Quarter (2699 shares)10.09114.08
Gains per Year (2699 shares)40.35456.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10403074382446
208170149764902
3012111022311461358
4016115029715281814
5020219037119102270
6024223044622922726
7028227052026743182
8032331059430563638
9036335066934384094
10040339074338204550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%2.09.012.08.7%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%13.010.00.056.5%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%1.00.022.04.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.04.00.060.0%14.09.00.060.9%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Aroa Biosurgery Ltd

About Aroa Biosurgery Ltd

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Fundamental data was last updated by Penke on 2024-02-14 06:35:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Aroa Biosurgery Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aroa Biosurgery Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aroa Biosurgery Ltd to the Medical Devices industry mean.
  • A Net Profit Margin of -0.6% means that $-0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aroa Biosurgery Ltd:

  • The MRQ is -0.6%. The company is not making a profit/loss.
  • The TTM is -0.6%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-0.6%0.0%
TTM-0.6%YOY-21.1%+20.5%
TTM-0.6%5Y-25.5%+24.9%
5Y-25.5%10Y-70.2%+44.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.6%-11.9%+11.3%
TTM-0.6%-18.7%+18.1%
YOY-21.1%-13.0%-8.1%
5Y-25.5%-18.4%-7.1%
10Y-70.2%-21.7%-48.5%
1.1.2. Return on Assets

Shows how efficient Aroa Biosurgery Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aroa Biosurgery Ltd to the Medical Devices industry mean.
  • -0.3% Return on Assets means that Aroa Biosurgery Ltd generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aroa Biosurgery Ltd:

  • The MRQ is -0.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-0.3%0.0%
TTM-0.3%YOY-7.4%+7.1%
TTM-0.3%5Y-7.3%+7.0%
5Y-7.3%10Y-11.5%+4.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.3%-3.5%+3.2%
TTM-0.3%-4.4%+4.1%
YOY-7.4%-3.7%-3.7%
5Y-7.3%-3.9%-3.4%
10Y-11.5%-4.4%-7.1%
1.1.3. Return on Equity

Shows how efficient Aroa Biosurgery Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aroa Biosurgery Ltd to the Medical Devices industry mean.
  • -0.4% Return on Equity means Aroa Biosurgery Ltd generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aroa Biosurgery Ltd:

  • The MRQ is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM-0.4%0.0%
TTM-0.4%YOY-8.3%+8.0%
TTM-0.4%5Y-8.6%+8.2%
5Y-8.6%10Y-18.7%+10.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%-4.2%+3.8%
TTM-0.4%-5.7%+5.3%
YOY-8.3%-4.2%-4.1%
5Y-8.6%-5.6%-3.0%
10Y-18.7%-6.4%-12.3%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Aroa Biosurgery Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aroa Biosurgery Ltd is operating .

  • Measures how much profit Aroa Biosurgery Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aroa Biosurgery Ltd to the Medical Devices industry mean.
  • An Operating Margin of -0.6% means the company generated $-0.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aroa Biosurgery Ltd:

  • The MRQ is -0.6%. The company is operating very inefficient. -2
  • The TTM is -0.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-0.6%0.0%
TTM-0.6%YOY-18.9%+18.3%
TTM-0.6%5Y-21.2%+20.6%
5Y-21.2%10Y-70.0%+48.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.6%-30.6%+30.0%
TTM-0.6%-13.1%+12.5%
YOY-18.9%-12.5%-6.4%
5Y-21.2%-17.7%-3.5%
10Y-70.0%-23.7%-46.3%
1.2.2. Operating Ratio

Measures how efficient Aroa Biosurgery Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are $1.14 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 1.137. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.137. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.137TTM1.1370.000
TTM1.137YOY1.300-0.163
TTM1.1375Y0.988+0.149
5Y0.98810Y1.639-0.651
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1371.452-0.315
TTM1.1371.452-0.315
YOY1.3001.436-0.136
5Y0.9881.461-0.473
10Y1.6391.375+0.264
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Aroa Biosurgery Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aroa Biosurgery Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 9.88 means the company has $9.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 9.877. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.877. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.877TTM9.8770.000
TTM9.877YOY11.903-2.026
TTM9.8775Y7.119+2.758
5Y7.11910Y5.684+1.436
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.8772.876+7.001
TTM9.8772.888+6.989
YOY11.9033.742+8.161
5Y7.1193.647+3.472
10Y5.6843.546+2.138
1.3.2. Quick Ratio

Measures if Aroa Biosurgery Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aroa Biosurgery Ltd to the Medical Devices industry mean.
  • A Quick Ratio of 12.22 means the company can pay off $12.22 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 12.218. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.218. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.218TTM12.2180.000
TTM12.218YOY18.747-6.529
TTM12.2185Y8.689+3.529
5Y8.68910Y4.763+3.926
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ12.2181.589+10.629
TTM12.2181.644+10.574
YOY18.7472.190+16.557
5Y8.6892.275+6.414
10Y4.7632.274+2.489
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Aroa Biosurgery Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aroa Biosurgery Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aroa Biosurgery Ltd to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.13 means that Aroa Biosurgery Ltd assets are financed with 12.6% credit (debt) and the remaining percentage (100% - 12.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 0.126. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.126. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.126TTM0.1260.000
TTM0.126YOY0.108+0.018
TTM0.1265Y0.287-0.161
5Y0.28710Y0.259+0.027
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1260.381-0.255
TTM0.1260.385-0.259
YOY0.1080.328-0.220
5Y0.2870.441-0.154
10Y0.2590.464-0.205
1.4.2. Debt to Equity Ratio

Measures if Aroa Biosurgery Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aroa Biosurgery Ltd to the Medical Devices industry mean.
  • A Debt to Equity ratio of 14.4% means that company has $0.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 0.144. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.144. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.144TTM0.1440.000
TTM0.144YOY0.121+0.023
TTM0.1445Y0.646-0.502
5Y0.64610Y1.062-0.417
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1440.547-0.403
TTM0.1440.557-0.413
YOY0.1210.464-0.343
5Y0.6460.612+0.034
10Y1.0620.691+0.371
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Aroa Biosurgery Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aroa Biosurgery Ltd generates.

  • Above 15 is considered overpriced but always compare Aroa Biosurgery Ltd to the Medical Devices industry mean.
  • A PE ratio of -910.64 means the investor is paying $-910.64 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is -494.347. Based on the earnings, the company is expensive. -2
  • The MRQ is -910.639. Based on the earnings, the company is expensive. -2
  • The TTM is -910.639. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-494.347MRQ-910.639+416.292
MRQ-910.639TTM-910.6390.000
TTM-910.639YOY-31.739-878.900
TTM-910.6395Y-179.172-731.467
5Y-179.17210Y-220.959+41.787
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-494.347-1.240-493.107
MRQ-910.639-1.757-908.882
TTM-910.639-2.394-908.245
YOY-31.739-2.576-29.163
5Y-179.172-2.034-177.138
10Y-220.959-1.818-219.141
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is -27.478. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -50.617. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -50.617. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-27.478MRQ-50.617+23.139
MRQ-50.617TTM-50.6170.000
TTM-50.617YOY-58.791+8.174
TTM-50.6175Y-81.739+31.122
5Y-81.73910Y-40.870-40.870
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-27.478-1.806-25.672
MRQ-50.617-2.532-48.085
TTM-50.617-3.776-46.841
YOY-58.791-6.182-52.609
5Y-81.739-5.741-75.998
10Y-40.870-6.142-34.728
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aroa Biosurgery Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 3.78 means the investor is paying $3.78 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is 2.053. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.781. Based on the equity, the company is fair priced.
  • The TTM is 3.781. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.053MRQ3.781-1.728
MRQ3.781TTM3.7810.000
TTM3.781YOY2.850+0.931
TTM3.7815Y3.949-0.168
5Y3.94910Y34.621-30.672
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.0532.161-0.108
MRQ3.7812.398+1.383
TTM3.7812.585+1.196
YOY2.8503.255-0.405
5Y3.9493.924+0.025
10Y34.6214.341+30.280
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aroa Biosurgery Ltd.

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Aroa Biosurgery Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0060.0060%0.116-95%0.054-89%0.025-77%
Book Value Per Share--0.2780.2780%0.272+2%0.185+50%0.101+176%
Current Ratio--9.8779.8770%11.903-17%7.119+39%5.684+74%
Debt To Asset Ratio--0.1260.1260%0.108+16%0.287-56%0.259-52%
Debt To Equity Ratio--0.1440.1440%0.121+19%0.646-78%1.062-86%
Dividend Per Share----0%-0%0.011-100%0.005-100%
Eps---0.001-0.0010%-0.024+2018%-0.019+1566%-0.011+894%
Free Cash Flow Per Share---0.021-0.0210%-0.013-36%-0.013-39%-0.013-39%
Free Cash Flow To Equity Per Share---0.022-0.0220%0.089-125%0.054-141%0.054-141%
Gross Profit Margin--121.477121.4770%4.662+2506%26.054+366%13.527+798%
Market Cap195761365.440-84%360613041.600360613041.6000%266166768.800+35%220832557.856+63%282840828.962+27%
Net Profit Margin---0.006-0.0060%-0.211+3281%-0.255+3976%-0.702+11138%
Operating Margin---0.006-0.0060%-0.189+3073%-0.212+3450%-0.700+11631%
Operating Ratio--1.1371.1370%1.300-13%0.988+15%1.639-31%
Pb Ratio2.053-84%3.7813.7810%2.850+33%3.949-4%34.621-89%
Pe Ratio-494.347+46%-910.639-910.6390%-31.739-97%-179.172-80%-220.959-76%
Price Per Share0.570-84%1.0501.0500%0.775+35%0.643+63%0.824+27%
Price To Free Cash Flow Ratio-27.478+46%-50.617-50.6170%-58.791+16%-81.739+61%-40.870-19%
Price To Total Gains Ratio99.122-84%182.592182.5920%6.703+2624%60.367+202%-66.595+136%
Quick Ratio--12.21812.2180%18.747-35%8.689+41%4.763+157%
Return On Assets---0.003-0.0030%-0.074+2090%-0.073+2059%-0.115+3298%
Return On Equity---0.004-0.0040%-0.083+2047%-0.086+2116%-0.187+4711%
Total Gains Per Share--0.0060.0060%0.116-95%0.065-91%0.030-81%
Usd Book Value--61985360.76361985360.7630%60701831.861+2%41246354.143+50%22480283.544+176%
Usd Book Value Change Per Share--0.0040.0040%0.075-95%0.035-89%0.016-77%
Usd Book Value Per Share--0.1800.1800%0.177+2%0.120+50%0.065+176%
Usd Dividend Per Share----0%-0%0.007-100%0.003-100%
Usd Eps---0.001-0.0010%-0.016+2018%-0.012+1566%-0.007+894%
Usd Free Cash Flow---4630149.679-4630149.6790%-2942339.342-36%-1693484.309-63%-846742.155-82%
Usd Free Cash Flow Per Share---0.013-0.0130%-0.009-36%-0.008-39%-0.008-39%
Usd Free Cash Flow To Equity Per Share---0.014-0.0140%0.058-125%0.035-141%0.035-141%
Usd Market Cap127225311.399-84%234362415.736234362415.7360%172981783.043+35%143519079.351+63%183818254.742+27%
Usd Price Per Share0.370-84%0.6820.6820%0.504+35%0.418+63%0.535+27%
Usd Profit---240906.485-240906.4850%-5065583.602+2003%-4003039.241+1562%-2415765.751+903%
Usd Revenue--38545037.90838545037.9080%23968800.075+61%21458574.108+80%11602780.145+232%
Usd Total Gains Per Share--0.0040.0040%0.075-95%0.042-91%0.020-81%
 EOD+2 -6MRQTTM+0 -0YOY+18 -165Y+22 -1410Y+24 -12

4.2. Fundamental Score

Let's check the fundamental score of Aroa Biosurgery Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-494.347
Price to Book Ratio (EOD)Between0-12.053
Net Profit Margin (MRQ)Greater than0-0.006
Operating Margin (MRQ)Greater than0-0.006
Quick Ratio (MRQ)Greater than112.218
Current Ratio (MRQ)Greater than19.877
Debt to Asset Ratio (MRQ)Less than10.126
Debt to Equity Ratio (MRQ)Less than10.144
Return on Equity (MRQ)Greater than0.15-0.004
Return on Assets (MRQ)Greater than0.05-0.003
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Aroa Biosurgery Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.550
Ma 20Greater thanMa 500.573
Ma 50Greater thanMa 1000.682
Ma 100Greater thanMa 2000.705
OpenGreater thanClose0.580
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets109,071
Total Liabilities13,695
Total Stockholder Equity95,377
 As reported
Total Liabilities 13,695
Total Stockholder Equity+ 95,377
Total Assets = 109,071

Assets

Total Assets109,071
Total Current Assets73,140
Long-term Assets35,932
Total Current Assets
Cash And Cash Equivalents 8,930
Short-term Investments 34,067
Net Receivables 13,413
Inventory 4,522
Other Current Assets 10,363
Total Current Assets  (as reported)73,140
Total Current Assets  (calculated)71,296
+/- 1,844
Long-term Assets
Property Plant Equipment 19,318
Goodwill 5,184
Intangible Assets 11,312
Long-term Assets Other 118
Long-term Assets  (as reported)35,932
Long-term Assets  (calculated)35,932
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities7,405
Long-term Liabilities6,289
Total Stockholder Equity95,377
Total Current Liabilities
Short-term Debt 523
Accounts payable 1,787
Other Current Liabilities 5,095
Total Current Liabilities  (as reported)7,405
Total Current Liabilities  (calculated)7,405
+/-0
Long-term Liabilities
Long term Debt Total 6,548
Deferred Long Term Liability 1,332
Long-term Liabilities  (as reported)6,289
Long-term Liabilities  (calculated)7,880
+/- 1,591
Total Stockholder Equity
Common Stock137,125
Retained Earnings -48,230
Accumulated Other Comprehensive Income 6,481
Total Stockholder Equity (as reported)95,377
Total Stockholder Equity (calculated)95,377
+/- 0
Other
Capital Stock137,125
Cash and Short Term Investments 42,997
Common Stock Shares Outstanding 342,917
Liabilities and Stockholders Equity 109,071
Net Debt -2,277
Net Invested Capital 95,377
Net Tangible Assets 85,600
Net Working Capital 65,734
Property Plant and Equipment Gross 27,601
Short Long Term Debt Total 6,653



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-31
> Total Assets 
13,851
12,365
12,121
15,441
19,600
40,578
88,532
71,603
83,083
5,131
8,075
10,928
9,357
8,406
7,510
6,355
6,515
15,208
39,460
82,536
73,125
104,706
109,071
109,071104,70673,12582,53639,46015,2086,5156,3557,5108,4069,35710,9288,0755,13183,08371,60388,53240,57819,60015,44112,12112,36513,851
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,816
1,761
833
922
9,457
13,152
55,253
44,753
74,244
73,140
73,14074,24444,75355,25313,1529,4579228331,7612,8160000000000000
       Cash And Cash Equivalents 
10,000
224
383
338
1,700
13,432
9,514
12,229
2,076
3,284
4,037
5,851
3,772
2,205
1,506
680
800
740
1,911
41,478
32,480
5,730
8,930
8,9305,73032,48041,4781,9117408006801,5062,2053,7725,8514,0373,2842,07612,2299,51413,4321,70033838322410,000
       Short-term Investments 
760
6,932
4,629
4,910
2,560
0
4,500
35
35
35
35
35
35
35
35
35
37
37
0
945
1,454
47,624
34,067
34,06747,6241,454945037373535353535353535354,50002,5604,9104,6296,932760
       Net Receivables 
11
49
89
184
112
95
7
88
20
63
34
38
310
461
61
4
9
2,641
5,466
7,328
6,599
15,958
13,413
13,41315,9586,5997,3285,4662,64194614613103834632088795112184894911
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,787
2,677
3,905
3,312
3,700
4,522
4,5223,7003,3123,9052,6771,78700000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,283
28,372
30,462
35,932
35,93230,46228,37227,2830000000000000000000
       Property Plant Equipment 
2,877
4,844
6,534
9,468
14,184
24,767
73,501
58,468
1,296
1,504
3,606
4,694
4,996
5,136
5,527
5,341
5,405
5,416
6,087
8,515
11,620
14,273
19,318
19,31814,27311,6208,5156,0875,4165,4055,3415,5275,1364,9964,6943,6061,5041,29658,46873,50124,76714,1849,4686,5344,8442,877
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,538
5,538
5,084
5,147
5,184
5,1845,1475,0845,5385,538000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
276
34
0
0
335
14,546
18,580
11,511
10,903
11,312
11,31210,90311,51118,58014,54633500342760000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
188
157
138
118
1181381571880000000000000000000
> Total Liabilities 
12,043
2,203
2,350
2,584
4,373
8,019
58,226
89,720
105,731
3,454
3,319
1,588
355
827
586
444
235
13,328
27,460
19,677
19,434
11,304
13,695
13,69511,30419,43419,67727,46013,3282354445868273551,5883,3193,454105,73189,72058,2268,0194,3732,5842,3502,20312,043
   > Total Current Liabilities 
12,025
2,203
1,304
1,719
3,156
2,851
11,733
50,132
99,205
209
1,772
1,489
201
628
331
375
175
2,394
8,154
6,128
14,038
6,238
7,405
7,4056,23814,0386,1288,1542,3941753753316282011,4891,77220999,20550,13211,7332,8513,1561,7191,3042,20312,025
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,030
9,656
547
523
5235479,6561,0300000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
820
9,136
0
0
009,1368200000000000000000000
       Accounts payable 
1,798
1,118
218
753
757
2,602
6,829
2,024
725
142
205
142
112
279
134
94
136
717
454
3,797
679
1,239
1,787
1,7871,2396793,797454717136941342791121422051427252,0246,8292,6027577532181,1181,798
       Other Current Liabilities 
9,208
66
67
66
1,499
244
917
6,676
98,480
68
69
72
88
348
197
35
37
737
363
1,302
3,703
4,451
5,095
5,0954,4513,7031,30236373737351973488872696898,4806,6769172441,4996667669,208
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,549
5,395
5,066
6,289
6,2895,0665,39513,5490000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,391
431
2,989
5,716
5,287
6,548
6,5485,2875,7162,9894311,39100000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,003
-3,889
4,914
6,129
6,1294,914-3,8891,0030000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,332
1,3320000000000000000000000
> Total Stockholder Equity
841
9,410
9,029
12,259
14,505
32,218
31,461
0
0
1,677
4,756
9,340
9,002
7,579
6,925
5,912
6,280
1,880
12,000
62,859
53,691
93,402
95,377
95,37793,40253,69162,85912,0001,8806,2805,9126,9257,5799,0029,3404,7561,6770031,46132,21814,50512,2599,0299,410841
   Retained Earnings -48,230-47,521-39,238-32,656-17,591-18,535-146,079-145,356-144,063-142,4470000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,218
3,591
5,450
6,481
6,4815,4503,5911,2180000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.